01 2ABBVIE
01 210286029
01 2Blank
01 2Blank
01 22034-03-14
Patent Expiration Date : 2034-03-14
US Patent Number : 10286029
Drug Substance Claim :
Drug Product Claim :
Application Number : 209394
Patent Use Code : U-3237
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-03-14
Patent Expiration Date : 2034-03-14
US Patent Number : 10286029
Drug Substance Claim :
Drug Product Claim :
Application Number : 215110
Patent Use Code : U-3238
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-03-14
